Osaic Holdings’s BioVie BIVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77 Hold
56
﹤0.01% 7651
2025
Q4
$64 Sell
56
-580
-91% -$934 ﹤0.01% 7677
2025
Q3
$618 Buy
636
+576
+960% +$2.33K ﹤0.01% 7491
2025
Q2
$548 Hold
60
﹤0.01% 7332
2025
Q1
$584 Hold
60
﹤0.01% 6961
2024
Q4
$1.2K Hold
60
﹤0.01% 6780
2024
Q3
$721 Buy
60
+20
+50% +$638 ﹤0.01% 6928
2024
Q2
$1.59K Sell
40
-18
-31% -$862 ﹤0.01% 6683
2024
Q1
$3.05K Sell
58
-13
-18% -$1.33K ﹤0.01% 6305
2023
Q4
$8.93K Sell
71
-17
-19% -$5.11K ﹤0.01% 5891
2023
Q3
$30.1K Sell
88
-2
-2% -$782 ﹤0.01% 5321
2023
Q2
$38.9K Buy
90
+10
+13% +$6.74K ﹤0.01% 5105
2023
Q1
$64.3K Sell
80
-17
-18% -$11.3K ﹤0.01% 4787
2022
Q4
$75K Buy
97
+67
+223% +$36.2K ﹤0.01% 4654
2022
Q3
$8K Buy
30
+27
+900% +$6.42K ﹤0.01% 6108
2022
Q2
$0 Sell
3
-7
-70% -$2.1K ﹤0.01% 7336
2022
Q1
$5K Hold
10
﹤0.01% 6456
2021
Q4
$5K Buy
10
+3
+43% +$1.73K ﹤0.01% 6609
2021
Q3
$4K Hold
7
﹤0.01% 6607
2021
Q2
$11K Buy
7
+5
+250% +$7.78K ﹤0.01% 5989
2021
Q1
$4K Sell
2
-8
-80% -$22.8K ﹤0.01% 6240
2020
Q4
$17K Sell
10
-50
-83% -$49.9K ﹤0.01% 5240
2020
Q3
$58K Buy
+60
New +$57K ﹤0.01% 4193

Other funds holding BIVI

Osaic Holdings's BIVI Position: Q1 2026 in Review

Osaic Holdings held its BioVie (BIVI) position steady in Q1 2026 at 56 shares worth $77. The position accounts for ﹤0.01% of the portfolio, ranked #7651.

Osaic Holdings first reported a position in BIVI in Q3 2020 and has held it in 23 quarters since. The position peaked at $75K in Q4 2022. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

  • Osaic Holdings held 56 shares of BioVie worth $77 as of Q1 2026.
  • Osaic Holdings left its BioVie share count unchanged in Q1 2026.
  • BioVie made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7651 holding.
  • Osaic Holdings first reported a position in BioVie in Q3 2020 and has held it in 23 quarters since.
  • Osaic Holdings's BioVie position peaked at $75K in Q4 2022.
  • 33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.